To address the functional relevance of ADAR1 and mTOR signaling, we used the mTOR kinase inhibitor, rapamycin, to treat GC cells and observe its effects on ADAR1-overexpressed cell proliferation and migration. The gene discussed is ADAR; the disease is gastric cancer.